Search company, investor...

SpineMatrix

spinematrix.com

Founded Year

2003

Stage

Series B | Alive

Total Raised

$7.1M

Last Raised

$7.1M | 16 yrs ago

About SpineMatrix

SpineMatrix, Inc. is a medical technology company engaged in spinal diagnostics. Akron-based SpineMatrix developed the Lumbar Matrix Scan, a diagnostic procedure to produce an all-inclusive physiological image of the lower back.

Headquarters Location

202 Montrose West Avenue Suite 360

Akron, Ohio, 44321,

United States

330-665-6780

Missing: SpineMatrix's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: SpineMatrix's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

SpineMatrix Patents

SpineMatrix has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/5/2006

10/4/2011

Electrophysiology, Muscular system, Neurophysiology, Cardiac arrhythmia, Electrodiagnosis

Grant

Application Date

10/5/2006

Grant Date

10/4/2011

Title

Related Topics

Electrophysiology, Muscular system, Neurophysiology, Cardiac arrhythmia, Electrodiagnosis

Status

Grant

SpineMatrix Frequently Asked Questions (FAQ)

  • When was SpineMatrix founded?

    SpineMatrix was founded in 2003.

  • Where is SpineMatrix's headquarters?

    SpineMatrix's headquarters is located at 202 Montrose West Avenue, Akron.

  • What is SpineMatrix's latest funding round?

    SpineMatrix's latest funding round is Series B.

  • How much did SpineMatrix raise?

    SpineMatrix raised a total of $7.1M.

  • Who are the investors of SpineMatrix?

    Investors of SpineMatrix include Psilos Group, Ohio Innovation Fund and Bounce Innovation Hub.

  • Who are SpineMatrix's competitors?

    Competitors of SpineMatrix include VIDA Diagnostics, Optovue, Akonni Biosystems, Mercator MedSystems, Stage I Diagnostics and 12 more.

Compare SpineMatrix to Competitors

N
Nanogen Adavanced Diagnostics S.r.l.

At Nanogen, Inc., the company develop diagnostic products that enable physicians to deliver improved patient care. The company's products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care. Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. The company's business focus is to bring better results to diagnostics and healthcare.

eSight Logo
eSight

eSight creates electronic glasses that restore or enhance sight for individuals living with vision loss. Worn comfortably like a normal pair of glasses or with prescription lenses built-in, they allow a person with low vision to see in virtually the same manner as someone who is fully-sighted can. The company's SPEX enhances vision for precision tasks, allowing users to pan and zoom the real world or streamed images, and brings critical information to the point of task without overwriting or obstructing natural vision for full situational awareness and mobility.

B
Biomatics

Biomatics commercializes advanced digital image processing for fully automated pathology diagnostics.

B
Biopticon

Biopticon Corporation is aimed to develop medical diagnostic devices using laser, photonics and image processing based technologies.

N
NIR Diagnostics

NIR Diagnostics is developing a diagnostic device to quantitatively assess the progress of the wound healing process. Per the company, the device has the potential to be a more accurate, more rapid, and less expensive method of wound assessment compared to those currently on the market.

D
Diamics

Diamics, Inc. is a medical device and diagnostics company. The company is developing, manufacturing, and marketing cost effective cancer diagnostic systems that will increase long-term cancer survival rates through early detection.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.